These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 8763057)

  • 1. [Fluvoxamine and serotonin syndrome in a patient with Parkinson disease].
    Le Cavorzin P; Sarkis S; Bénéton C; Pinel JF; Maruelle L; Le Vaou P; Allain H
    Therapie; 1996; 51(2):195-6. PubMed ID: 8763057
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluvoxamine-induced bullous eruption mimicking hand-foot syndrome and intertrigo-like eruption: rare cutaneous presentations and elusive pathogenesis.
    Ke CL; Chen CC; Lin CT; Chen GS; Chai CY; Cheng ST
    J Am Acad Dermatol; 2006 Aug; 55(2):355-6. PubMed ID: 16844531
    [No Abstract]   [Full Text] [Related]  

  • 3. EPMS under antidepressive therapy with fluvoxamine and concomitant antibiotic therapy with clindamycin.
    Jakob F; Wolf J
    Pharmacopsychiatry; 2007 May; 40(3):129. PubMed ID: 17541891
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversible tremor and myoclonus associated with topiramate-fluvoxamine coadministration.
    Oulis P; Potagas C; Masdrakis VG; Thomopoulos Y; Kouzoupis AV; Soldatos CR
    Clin Neuropharmacol; 2008; 31(6):366-7. PubMed ID: 19050415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schneiderian first-rank symptoms associated with fluvoxamine treatment: a case report.
    Ueda N; Terao T; Ohmori O; Nakamura J
    Hum Psychopharmacol; 2003 Aug; 18(6):477-8. PubMed ID: 12923827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fluvoxamine and convulsive syncope: case report].
    Régina W; Vandel S
    Therapie; 1998; 53(5):504-5. PubMed ID: 9921046
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug interaction of tizanidine and fluvoxamine.
    Momo K; Doki K; Hosono H; Homma M; Kohda Y
    Clin Pharmacol Ther; 2004 Nov; 76(5):509-10. PubMed ID: 15536467
    [No Abstract]   [Full Text] [Related]  

  • 8. The serotonin syndrome and psychosis-like side-effects of fluvoxamine clinical use--an estimation of incidence.
    Ebert D; Albert R; May A; Merz A; Murata H; Stosiek I; Zahner B
    Eur Neuropsychopharmacol; 1997 Feb; 7(1):71-4. PubMed ID: 9088888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single dose of fluvoxamine associated with an acute psychotic reaction.
    Sim FH; Massabki RA
    Can J Psychiatry; 2000 Oct; 45(8):762. PubMed ID: 11086561
    [No Abstract]   [Full Text] [Related]  

  • 10. Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees.
    Franchini L; Serretti A; Gasperini M; Smeraldi E
    J Psychiatr Res; 1998; 32(5):255-9. PubMed ID: 9789202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe diurnal somnolence induced by fluvoxamine-lithium combination.
    Marchesi C; Paini M; Maggini C
    Pharmacopsychiatry; 2005 May; 38(3):145-6. PubMed ID: 15902588
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
    Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
    Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herbal medicine in the treatment of fluvoxamine-induced nausea and dyspepsia.
    Yamada K; Kanba S; Yagi G; Asai M
    Psychiatry Clin Neurosci; 1999 Dec; 53(6):681. PubMed ID: 10687751
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors of antidepressant response to fluvoxamine obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale for major depressive disorders in Japanese patients.
    Higuchi H; Sato K; Yoshida K; Takahashi H; Kamata M; Otani K; Yamaguchi N
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):301-6. PubMed ID: 18588590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study.
    Terra JL; Montgomery SA
    Int Clin Psychopharmacol; 1998 Mar; 13(2):55-62. PubMed ID: 9669185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin syndrome from fluvoxamine and buspirone.
    Baetz M; Malcolm D
    Can J Psychiatry; 1995 Sep; 40(7):428-9. PubMed ID: 8548727
    [No Abstract]   [Full Text] [Related]  

  • 18. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial.
    Spivak B; Strous RD; Shaked G; Shabash E; Kotler M; Weizman A
    J Clin Psychopharmacol; 2006 Apr; 26(2):152-6. PubMed ID: 16633143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of adolescent body dysmorphic disorder treated with fluvoxamine.
    Khan S; Decker D
    J Child Adolesc Psychopharmacol; 2001; 11(1):105-7. PubMed ID: 11322739
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful electroconvulsive therapy in major depression with fluvoxamine-induced bruxism.
    Miyaoka T; Yasukawa R; Mihara T; Shimizu Y; Tsubouchi K; Maeda T; Mizuno S; Uegaki J; Inagaki T; Horiguchi J; Tachibana H
    J ECT; 2003 Sep; 19(3):170-2. PubMed ID: 12972988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.